Germany
· Delayed Price · Currency is EUR Thermo Fisher Scientific Statistics
Total Valuation
ETR:TN8 has a market cap or net worth of EUR 174.20 billion. The enterprise value is 199.45 billion.
| Market Cap | 174.20B |
| Enterprise Value | 199.45B |
Important Dates
The next estimated earnings date is Wednesday, April 23, 2025.
| Earnings Date | Apr 23, 2025 |
| Ex-Dividend Date | Mar 14, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -1.29% |
| Shares Change (QoQ) | -0.26% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 376.45M |
Valuation Ratios
The trailing PE ratio is 28.47.
| PE Ratio | 28.47 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.25, with an EV/FCF ratio of 28.41.
| EV / Earnings | 32.60 |
| EV / Sales | 5.04 |
| EV / EBITDA | 19.25 |
| EV / EBIT | 28.26 |
| EV / FCF | 28.41 |
Financial Position
The company has a current ratio of 1.66, with a Debt / Equity ratio of 0.66.
| Current Ratio | 1.66 |
| Quick Ratio | 1.14 |
| Debt / Equity | 0.66 |
| Debt / EBITDA | 2.92 |
| Debt / FCF | 4.52 |
| Interest Coverage | 5.53 |
Financial Efficiency
Return on equity (ROE) is 13.13% and return on invested capital (ROIC) is 5.79%.
| Return on Equity (ROE) | 13.13% |
| Return on Assets (ROA) | 4.90% |
| Return on Invested Capital (ROIC) | 5.79% |
| Return on Capital Employed (ROCE) | 9.15% |
| Revenue Per Employee | 331,335 |
| Profits Per Employee | 48,952 |
| Employee Count | 125,000 |
| Asset Turnover | 0.44 |
| Inventory Turnover | 5.00 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -10.58% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -10.58% |
| 50-Day Moving Average | 512.44 |
| 200-Day Moving Average | 523.56 |
| Relative Strength Index (RSI) | 33.46 |
| Average Volume (20 Days) | 205 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.24 |
Income Statement
In the last 12 months, ETR:TN8 had revenue of EUR 41.42 billion and earned 6.12 billion in profits. Earnings per share was 15.97.
| Revenue | 41.42B |
| Gross Profit | 17.10B |
| Operating Income | 7.42B |
| Pretax Income | 6.76B |
| Net Income | 6.12B |
| EBITDA | 10.43B |
| EBIT | 7.42B |
| Earnings Per Share (EPS) | 15.97 |
Balance Sheet
The company has 5.38 billion in cash and 31.71 billion in debt, giving a net cash position of -26.33 billion.
| Cash & Cash Equivalents | 5.38B |
| Total Debt | 31.71B |
| Net Cash | -26.33B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 47.98B |
| Book Value Per Share | 125.78 |
| Working Capital | 8.50B |
Cash Flow
In the last 12 months, operating cash flow was 8.37 billion and capital expenditures -1.35 billion, giving a free cash flow of 7.02 billion.
| Operating Cash Flow | 8.37B |
| Capital Expenditures | -1.35B |
| Free Cash Flow | 7.02B |
| FCF Per Share | n/a |
Margins
Gross margin is 41.28%, with operating and profit margins of 17.93% and 14.77%.
| Gross Margin | 41.28% |
| Operating Margin | 17.93% |
| Pretax Margin | 16.31% |
| Profit Margin | 14.77% |
| EBITDA Margin | 25.18% |
| EBIT Margin | 17.93% |
| FCF Margin | 16.95% |
Dividends & Yields
This stock pays an annual dividend of 1.48, which amounts to a dividend yield of 0.31%.
| Dividend Per Share | 1.48 |
| Dividend Yield | 0.31% |
| Dividend Growth (YoY) | 11.49% |
| Years of Dividend Growth | 5 |
| Payout Ratio | 9.20% |
| Buyback Yield | 1.29% |
| Shareholder Yield | 1.60% |
| Earnings Yield | 3.51% |
| FCF Yield | 4.03% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ETR:TN8 has an Altman Z-Score of 4.31.
| Altman Z-Score | 4.31 |
| Piotroski F-Score | n/a |